Trial intelligence / Profile preview

iPACK Block With ACB and LIA for Postoperative Pain in Total Knee Arthroplasty

NCT04635176Phase 4Terminated

Sponsor
University of Calgary
Start
Oct 2022
Primary completion
May 2026
Modality
Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of bupivacaine, epinephrine, dexamethasone in postoperative pain, sponsored by University of Calgary. Started Oct 2022; status: terminated.

02

Drugs

bupivacaineepinephrinedexamethasone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04635176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04635176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call